Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 7, Issue : 3, Year : 2021
Article Page : 528-531
https://doi.org/10.18231/j.ijceo.2021.104
Abstract
The prospective study was carried out at Netaji Subhash Chandra Bose, medical college, Jabalpur, from 2017-2020, on 30 recipients, who underwent penetrating keratoplasty. The results of the surgery were studied prospectively over a period of 6 months, with follow up at 7 days, 1 month, month and 6 months. Study design: Longitudinal follow up. In our study, penetrating keratoplasty done for optical indications (67%) resulted in fairly good visual outcome, compared to those done for therapeutic indications (23%). The most common complication was corneal vascularisation (56%), and least common was secondary glaucoma (6.66%).
Keywords: Penetrating keratoplasty, Optical therapeutic.
How to cite : Shrivastava P, Saxena N, Clinical evaluation of penetrating keratoplasty and its visual outcome. Indian J Clin Exp Ophthalmol 2021;7(3):528-531
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
